[{"edinetCode":"E00949","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3667.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":141829000.0,"sharesOwendPercent":0.3492,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":28.7,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2017\/6\/23","stockCode":4536,"accountingYear":"第105期（自　2016年４月１日　至　2017年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3805.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":152572000.0,"sharesOwendPercent":0.375,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":19.8,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/6\/26","stockCode":4536,"accountingYear":"第106期（自　2017年４月１日　至　2018年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":4073.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":156150000.0,"sharesOwendPercent":0.3912,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":391186000000.0,"currentAssets":194742000000.0,"fixedAsset":null,"tangibleFixedAssets":31699000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":98614000000.0,"currentLiabilities":60663000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8252000000.0,"capitalSurplus":8661000000.0,"accumulatedEarnings":258659000000.0,"treasuryStock":-1131000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":90764000000.0,"grossProfit":null,"sgaExpenses":71273000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":21.0,"roe":null,"cashFlowFromOperatingActivities":32894000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-2935000000.0,"cashFlowFromFinancialActivities":-28107000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2019\/6\/25","stockCode":4536,"accountingYear":"第107期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":386304000000.0,"currentAssets":188328000000.0,"fixedAsset":null,"tangibleFixedAssets":39144000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":96447000000.0,"currentLiabilities":52812000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8283000000.0,"capitalSurplus":8715000000.0,"accumulatedEarnings":260287000000.0,"treasuryStock":-1131000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":24120000000.0,"grossProfit":null,"sgaExpenses":16047000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":4999000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-1355000000.0,"cashFlowFromFinancialActivities":-5743000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/2","stockCode":4536,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":160512000.0,"sharesOwendPercent":0.402,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":397073000000.0,"currentAssets":202428000000.0,"fixedAsset":null,"tangibleFixedAssets":38291000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":101881000000.0,"currentLiabilities":59583000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8287000000.0,"capitalSurplus":8631000000.0,"accumulatedEarnings":267452000000.0,"treasuryStock":-1011000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":48302000000.0,"grossProfit":null,"sgaExpenses":33422000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":23588000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-1908000000.0,"cashFlowFromFinancialActivities":-5962000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2019\/11\/8","stockCode":4536,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":407712000000.0,"currentAssets":207411000000.0,"fixedAsset":null,"tangibleFixedAssets":39211000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":103900000000.0,"currentLiabilities":58954000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8296000000.0,"capitalSurplus":8683000000.0,"accumulatedEarnings":269907000000.0,"treasuryStock":-1033000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":74357000000.0,"grossProfit":null,"sgaExpenses":52835000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":27362000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-3528000000.0,"cashFlowFromFinancialActivities":-11514000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/7","stockCode":4536,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":4108.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":160878000.0,"sharesOwendPercent":0.4028,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":408768000000.0,"currentAssets":218556000000.0,"fixedAsset":null,"tangibleFixedAssets":35601000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":106208000000.0,"currentLiabilities":67597000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8366000000.0,"capitalSurplus":8746000000.0,"accumulatedEarnings":273422000000.0,"treasuryStock":-1033000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":94831000000.0,"grossProfit":null,"sgaExpenses":73360000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":31.4,"roe":null,"cashFlowFromOperatingActivities":39947000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-5175000000.0,"cashFlowFromFinancialActivities":-12729000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2020\/6\/24","stockCode":4536,"accountingYear":"第108期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":409586000000.0,"currentAssets":209053000000.0,"fixedAsset":null,"tangibleFixedAssets":35735000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":103762000000.0,"currentLiabilities":62337000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8411000000.0,"capitalSurplus":8833000000.0,"accumulatedEarnings":274018000000.0,"treasuryStock":-1033000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":24741000000.0,"grossProfit":null,"sgaExpenses":15551000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":7445000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-10564000000.0,"cashFlowFromFinancialActivities":-6012000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/7","stockCode":4536,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":164542000.0,"sharesOwendPercent":0.4117,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":420021000000.0,"currentAssets":187083000000.0,"fixedAsset":null,"tangibleFixedAssets":36219000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":104387000000.0,"currentLiabilities":65732000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8411000000.0,"capitalSurplus":8763000000.0,"accumulatedEarnings":281643000000.0,"treasuryStock":-931000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":49705000000.0,"grossProfit":null,"sgaExpenses":33242000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":18428000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-44734000000.0,"cashFlowFromFinancialActivities":-6771000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2020\/11\/11","stockCode":4536,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":413087000000.0,"currentAssets":183892000000.0,"fixedAsset":null,"tangibleFixedAssets":35648000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":98357000000.0,"currentLiabilities":62020000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8446000000.0,"capitalSurplus":8842000000.0,"accumulatedEarnings":284558000000.0,"treasuryStock":-934000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":75897000000.0,"grossProfit":null,"sgaExpenses":52821000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":23824000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-50311000000.0,"cashFlowFromFinancialActivities":-12956000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/8","stockCode":4536,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":4229.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":157337000.0,"sharesOwendPercent":0.3935,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":402353000000.0,"currentAssets":206231000000.0,"fixedAsset":null,"tangibleFixedAssets":39489000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":95303000000.0,"currentLiabilities":78549000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8525000000.0,"capitalSurplus":8954000000.0,"accumulatedEarnings":270757000000.0,"treasuryStock":-934000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":98221000000.0,"grossProfit":null,"sgaExpenses":79554000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":89.1,"roe":null,"cashFlowFromOperatingActivities":38808000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-53355000000.0,"cashFlowFromFinancialActivities":-16685000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2021\/6\/25","stockCode":4536,"accountingYear":"第109期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":397096000000.0,"currentAssets":197007000000.0,"fixedAsset":null,"tangibleFixedAssets":41644000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":86055000000.0,"currentLiabilities":68158000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8525000000.0,"capitalSurplus":8992000000.0,"accumulatedEarnings":272724000000.0,"treasuryStock":-934000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":26924000000.0,"grossProfit":null,"sgaExpenses":20447000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":2540000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-4882000000.0,"cashFlowFromFinancialActivities":-6173000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/11","stockCode":4536,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":178490000.0,"sharesOwendPercent":0.4462,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":420435000000.0,"currentAssets":211182000000.0,"fixedAsset":null,"tangibleFixedAssets":49082000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":101407000000.0,"currentLiabilities":75254000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8538000000.0,"capitalSurplus":8860000000.0,"accumulatedEarnings":282296000000.0,"treasuryStock":-718000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":52867000000.0,"grossProfit":null,"sgaExpenses":39652000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":27096000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-17057000000.0,"cashFlowFromFinancialActivities":2972000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2021\/11\/10","stockCode":4536,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0},{"edinetCode":"E00949","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":429598000000.0,"currentAssets":209004000000.0,"fixedAsset":null,"tangibleFixedAssets":51343000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":108823000000.0,"currentLiabilities":80893000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8544000000.0,"capitalSurplus":9068000000.0,"accumulatedEarnings":281098000000.0,"treasuryStock":-718000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":82704000000.0,"grossProfit":null,"sgaExpenses":60323000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":31188000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-23237000000.0,"cashFlowFromFinancialActivities":-4148000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":4536,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00949","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8296,"settlementDate":"2022\/3\/31","submitterName":"参天製薬株式会社","submitterNameEnglish":"SANTEN PHARMACEUTICAL CO.,LTD.","submitterNameKana":"サンテンセイヤクカブシキガイシャ","location":"大阪市北区大深町４番２０号","industory":"医薬品","corporateNumber":5120000000000.0}]